Praxis Precision Medicines Inc (PRAX)
45.27
+0.06
(+0.13%)
USD |
NASDAQ |
May 17, 16:00
45.27
0.00 (0.00%)
After-Hours: 20:00
Praxis Precision Medicines Free Cash Flow: -99.15M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -99.15M |
| December 31, 2023 | -111.14M |
| September 30, 2023 | -116.08M |
| June 30, 2023 | -137.78M |
| March 31, 2023 | -163.78M |
| December 31, 2022 | -185.49M |
| September 30, 2022 | -202.07M |
| Date | Value |
|---|---|
| June 30, 2022 | -181.52M |
| March 31, 2022 | -154.28M |
| December 31, 2021 | -125.60M |
| September 30, 2021 | -99.92M |
| June 30, 2021 | -89.84M |
| March 31, 2021 | -69.78M |
| December 31, 2020 | -52.62M |
Free Cash Flow Range, Past 5 Years
-202.07M
Minimum
Sep 2022
-52.62M
Maximum
Dec 2020
-127.79M
Average
-120.84M
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals Inc | 81.59M |
| Regeneron Pharmaceuticals Inc | 3.930B |
| Atossa Therapeutics Inc | -18.64M |
| ADMA Biologics Inc | 15.91M |
| Viking Therapeutics Inc | -54.87M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -20.86M |
| Cash from Investing (Quarterly) | -91.22M |
| Cash from Financing (Quarterly) | 182.76M |
| Free Cash Flow Per Share (Quarterly) | -1.50 |
| Free Cash Flow to Equity (Quarterly) | -20.86M |
| Free Cash Flow Yield | -23.82% |